Published on in Vol 8, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19588, first published .
Nomogram for Predicting COVID-19 Disease Progression Based on Single-Center Data: Observational Study and Model Development

Nomogram for Predicting COVID-19 Disease Progression Based on Single-Center Data: Observational Study and Model Development

Nomogram for Predicting COVID-19 Disease Progression Based on Single-Center Data: Observational Study and Model Development

Journals

  1. Chen X, Peng F, Zhou X, Zhu J, Chen X, Gong Y, Shupeng W, Niu W. Predicting severe or critical symptoms in hospitalized patients with COVID-19 from Yichang, China. Aging 2021;13(2):1608 View
  2. Karaismailoglu E, Karaismailoglu S. Two novel nomograms for predicting the risk of hospitalization or mortality due to COVID‐19 by the naïve Bayesian classifier method. Journal of Medical Virology 2021;93(5):3194 View
  3. Wynants L, Van Calster B, Collins G, Riley R, Heinze G, Schuit E, Albu E, Arshi B, Bellou V, Bonten M, Dahly D, Damen J, Debray T, de Jong V, De Vos M, Dhiman P, Ensor J, Gao S, Haller M, Harhay M, Henckaerts L, Heus P, Hoogland J, Hudda M, Jenniskens K, Kammer M, Kreuzberger N, Lohmann A, Levis B, Luijken K, Ma J, Martin G, McLernon D, Navarro C, Reitsma J, Sergeant J, Shi C, Skoetz N, Smits L, Snell K, Sperrin M, Spijker R, Steyerberg E, Takada T, Tzoulaki I, van Kuijk S, van Bussel B, van der Horst I, Reeve K, van Royen F, Verbakel J, Wallisch C, Wilkinson J, Wolff R, Hooft L, Moons K, van Smeden M. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 2020:m1328 View
  4. Zhu F, Gu B, Jin Y, Yao L, Zhou L, Zou D, Ding J, Zhou T, Shen X, Chen C. Risk Factors for Radiological Progression Within Admissive One Week in the Hospitalized COVID-19 Omicron Variant-Infected Patients. Infection and Drug Resistance 2022;Volume 15:7127 View
  5. Singla K, Puri G, Guha Niyogi S, Mahajan V, Kajal K, Bhalla A. Predictors of the Outcomes Following the Tocilizumab Treatment for Severe COVID-19. Cureus 2022 View
  6. Mohammedain S, Badran S, Elzouki A, Salim H, Chalaby A, Siddiqui M, Hussein Y, Rahim H, Thalib L, Alam M, Al-Badriyeh D, Al-Maadeed S, Doi S. Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study. Future Virology 2023;18(15):991 View
  7. Zelek W, Harrison R. Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know. Immunobiology 2023;228(3):152393 View